VentureBeat January 14, 2022
Verana Health, a digital health company that leverages big data insights to enhance medical research, has raised $150 million in a series E round of funding.
The San Francisco-based company has formed exclusive data partnerships with a number of notable medical associations, including the American Academy of Ophthalmology, the American Academy of Neurology, and the American Urological Association, to aggregate and analyze anonymized patient data and expedite the development of new drugs. It also claims to work with numerous multinational pharmaceutical companies and “emerging biotechnology and biopharmaceutical companies.”
AI meets healthcare
Verana Health has two core products — the VeraQ platform, which is pitched as a health data engine that connects disparate, unfiltered healthcare data; and Qdata, which are data...
Today's Sponsors
Today's Sponsor